GRAL
GRAIL Inc · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website grail.com
- Employees(FY) -
- ISIN US3847471014
Performance
-11.69%
1W
+24.07%
1M
+32.3%
3M
+14.4%
6M
+34.33%
YTD
+34.33%
1Y
Profile
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
Recent News & Updates
- 2024-12-18 16:01
- 2024-12-18 03:01
- 2024-12-16 13:43
- 2024-12-10 14:52
One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's(Investor's Business Daily)
- 2024-12-05 13:40
Stock Market Today: Dow Jones Keeps Losses Tidy As New Medical IPO Breaks Out (Live Coverage)(Investor's Business Daily)
- 2024-12-03 16:01
- 2024-12-03 03:01
- 2024-11-27 11:21
- 2024-11-19 16:23
- 2024-11-19 16:05
- 2024-11-19 03:05
- 2024-11-18 17:10
- 2024-11-18 16:01
- 2024-11-18 03:01
- 2024-11-17 20:16
- 2024-11-14 14:00
- 2024-11-14 05:13
- 2024-11-12 16:06
GRAIL Reports Third Quarter 2024 Financial Results(PR Newswire)
- 2024-11-12 03:06
- 2024-11-04 16:01
- 2024-11-04 03:01
- 2024-10-29 16:01
- 2024-10-29 04:01
- 2024-10-23 18:00
- 2024-10-23 06:00
- 2024-10-21 16:01
GRAIL Appoints Sarah Krevans to Board of Directors(PR Newswire)
- 2024-10-21 04:01
- 2024-10-15 14:00
- 2024-10-13 16:59
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now(Insider Monkey)
- 2024-10-13 04:59
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now(Insidermonkey)
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.